tiprankstipranks
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
US Market
BBOT
BridgeBio Oncology Therapeutics
RESEARCH TOOLSreports
Want to see BBOT full AI Analyst Report?

BridgeBio Oncology Therapeutics (BBOT) Income Statement

57 Followers

BridgeBio Oncology Therapeutics Income Statement

Last quarter (Q1 2026), BridgeBio Oncology Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, BridgeBio Oncology Therapeutics's net income was $-42.11M. See BridgeBio Oncology Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 145.82M$ 80.86M$ 64.77M$ 3.52K$ 43.36K
Depreciation and Amortization
$ 610.00K$ 208.00K$ 92.00K$ 0.00$ 0.00
EBITDA
$ -145.21M$ -80.66M$ -64.68M$ -3.52K$ -43.36K
Operating Income
$ -145.82M$ -80.86M$ -64.77M$ -3.52K$ -43.36K
Other Income/Expenses
$ 11.78M$ 8.18M$ 72.00K$ 0.00$ 0.00
Pretax Income
$ -134.04M$ -74.28M$ -64.70M$ -3.52K$ -43.36K
Net Income
$ -134.04M$ -74.28M$ -64.70M$ -3.52K$ -43.36K
Per Share Metrics
Basic EPS
$ -4.30$ 0.46$ >-0.01$ <0.01$ 0.00
Diluted EPS
$ -4.30$ 0.46$ >-0.01$ >-0.01$ 0.00
Weighted Average Shares Outstanding
 31.14M 16.64M 20.48M 20.48M 20.48M
Weighted Average Shares Outstanding (Diluted)
 31.14M 16.64M 20.48M 20.48M 20.48M
Currency in USD

BridgeBio Oncology Therapeutics Earnings and Revenue History